Company profile
Avricore Health Inc.
OTC: AVCRF · Healthcare · Medical - Diagnostics & Research
Canadian filerHQ Vancouver, BCCIK 0001355736Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 44
v0.1 · 5/100 weight · pillars only
↑ balance-sheet leverage, listing tenure · ↓ filing timeliness, Piotroski F
Methodology →Revenue TTM
$104.5k
Rev growth YoY (TTM)
-96.5%
Net income (FY)
-$488.4k
Employees
26
as of 2026-09-22
Market cap
$81.0k
as of 2026-09-22
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$488.4k-669.0k CAD2024
Total assets$1.6M2.3M CAD2024
Liabilities$229.9k330.8k CAD2024
Revenue by segment
Filed disclosures · FY2024
By product
Sale of products51%
Lease and service49%
By geography
Not disclosed.
The read
What is Avricore Health Inc.’s financial profile?
Avricore Health Inc. earned -$488.4k in FY2024 net income.
Peers · Healthcare
Akanda Corp.——Mobile Lads Corp.——Lotus Pharmaceuticals, Inc.——Psyence Biomedical Ltd.——Indocan Resources Inc.——Patient Access Solutions, Inc.——Key facts
CEORodger Seccombe
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersVancouver, BC
ExchangeOTC: AVCRF
Employees26
IPO date2009-06-19
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.